Article info

Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies ± other therapies in lung cancer: a systematic review and meta-analysis

Authors

  1. Correspondence to Dr Bin Xiong, Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China; xionbin321{at}163.com
View Full Text

Citation

Shen X, Huang S, Xiao H, et al
Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies ± other therapies in lung cancer: a systematic review and meta-analysis

Publication history

  • Received March 22, 2021
  • Accepted August 24, 2021
  • First published September 8, 2021.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.